These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15653150

  • 1. Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration.
    Sigurdsson HH, Stefánsson E, Gudmundsdóttir E, Eysteinsson T, Thorsteinsdóttir M, Loftsson T.
    J Control Release; 2005 Jan 20; 102(1):255-62. PubMed ID: 15653150
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.
    Park CG, Kim YK, Kim SN, Lee SH, Huh BK, Park MA, Won H, Park KH, Choy YB.
    Int J Pharm; 2017 Apr 30; 522(1-2):66-73. PubMed ID: 28216468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of a single dose of topical 0.005% latanoprost and 2% dorzolamide/0.5% timolol combination on the blood-aqueous barrier in dogs: a pilot study.
    Johnstone McLean NS, Ward DA, Hendrix DV.
    Vet Ophthalmol; 2008 Apr 30; 11(3):158-61. PubMed ID: 18435656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
    Kristinsson JK, Fridriksdóttir H, Thórisdóttir S, Sigurdardóttir AM, Stefánsson E, Loftsson T.
    Invest Ophthalmol Vis Sci; 1996 May 30; 37(6):1199-203. PubMed ID: 8631635
    [Abstract] [Full Text] [Related]

  • 14. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery.
    Ammar HO, Salama HA, Ghorab M, Mahmoud AA.
    Drug Dev Ind Pharm; 2010 Nov 30; 36(11):1330-9. PubMed ID: 20545523
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S, Gümüş K, Gümüş O, Unlü N.
    Eur J Pharm Biopharm; 2008 Sep 30; 70(1):260-9. PubMed ID: 18590953
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans.
    Schmitz K, Banditt P, Motschmann M, Meyer FP, Behrens-Baumann W.
    Invest Ophthalmol Vis Sci; 1999 Jun 30; 40(7):1621-4. PubMed ID: 10359348
    [Abstract] [Full Text] [Related]

  • 18. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L, Zhang J, Wang L, Xia H.
    Curr Eye Res; 2009 Apr 30; 34(4):257-63. PubMed ID: 19373573
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
    Afouna MI, Khedr A, Abdel-Naim AB, Al-Marzoqi A.
    J Pharm Sci; 2010 Jan 30; 99(1):119-27. PubMed ID: 19530071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.